forgemax.FORGED. TESTED. PROVEN.
AnaTrex 10mg/tab 100 Tabletten by Concentrex Labs
Batch Tested

AnaTrex 10mg/tab 100 Tabletten by Concentrex Labs

4.5 (2 reviews)

AnaTrex by Concentrex Labs delivers Methandienone at 10 mg per tablet across a 100-tablet count, formulated specifically around the pharmacological reality that prolonged androgen receptor exposure drives progressive desensitization — making structured cycle limits a scientific necessity rather than a precaution. Each tablet provides a measured dose engineered to maximize anabolic signaling before receptor downregulation attenuates the response curve. Quality is confirmed at the finished-product stage: every AnaTrex batch undergoes HPLC potency verification and LAL endotoxin screening before release, with batch records archived and available on request.

€26.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Precisely dosed at 10 mg per tablet for controlled daily androgen receptor loading
  • 100-tablet pack supports a full structured cycle with titration flexibility built in
  • Tablet format allows dose splitting across the day to manage receptor pressure timing
  • HPLC-verified potency at finished-product stage — not just raw-material intake
  • LAL endotoxin-tested batch release provides an additional analytical safety checkpoint
  • Concentrex Labs' batch records are archived, supporting verifiable product traceability
  • Short-duration cycle planning is supported by the discrete 10 mg unit dose structure

Key takeaways

  • Understand receptor desensitization before planning any Methandienone cycle length.
  • Limit continuous AnaTrex use to six weeks to preserve anabolic receptor responsiveness.
  • Observe a recovery break equal to or longer than your cycle duration.
  • Split daily 10 mg tablet doses to moderate receptor stimulation pressure throughout the day.
  • Verify batch quality via Concentrex Labs' HPLC-confirmed and LAL-tested release documentation.

Receptor Tolerance and Desensitization: Why the Body Adapts to Methandienone

Methandienone is an orally active 17α-alkylated anabolic-androgenic steroid whose clinical relevance is inseparable from the phenomenon of androgen receptor desensitization — the process by which continuous ligand exposure causes the receptor population to downregulate, reducing anabolic signal output even when circulating drug concentrations remain constant. Receptor desensitization operates at the cellular level: prolonged agonist binding triggers internalization of androgen receptor complexes, reduces receptor re-synthesis rates, and ultimately blunts the transcriptional response in skeletal-muscle nuclei. This is distinct from pharmacokinetic tolerance, which involves changes in drug absorption or clearance — desensitization is a receptor-level event measurable by reduced mRNA expression of androgen-responsive genes such as IGF-1 and follistatin.

How Quickly Does Desensitization Develop with Methandienone?

Anabolic response attenuation is detectable within four to six weeks of uninterrupted Methandienone use, according to clinical observations documented in the sports-pharmacology literature using nitrogen retention as a surrogate endpoint. Compared to long-ester testosterone protocols — where receptor occupancy fluctuates with ester release kinetics — short-acting oral Methandienone maintains near-continuous receptor pressure due to its multiple-daily-dose schedule, which paradoxically accelerates the desensitization timeline. Concentrex Labs' AnaTrex delivers 10 mg per tablet at a tablet count of 100, giving the user a format that supports the split-dose strategies most commonly employed before receptor downregulation becomes the rate-limiting factor in anabolic output.

Cycle Length, Off-Time, and Receptor Recovery

Receptor recovery following downregulation requires a drug-free interval during which receptor synthesis can re-establish baseline density; research using radioligand binding assays in androgen-sensitive tissue models suggests this normalization period spans approximately four to eight weeks, mirroring the common "cycle equals off-time" guideline. Rotating Methandienone cycles with adequate receptor-recovery windows prevents cumulative blunting of the anabolic response across successive cycles. AnaTrex tablets are individually dosed at 10 mg, enabling precise daily titration that allows users to taper down toward the end of a cycle — a strategy consistent with minimizing abrupt receptor-signal withdrawal while the off-phase begins.

Batch Testing and Quality Assurance

Every AnaTrex production lot is subject to HPLC-based quantitative assay at the finished-tablet stage, confirming that each tablet delivers 10 mg of Methandienone within the validated acceptance range recorded in the batch certificate. LAL (Limulus Amebocyte Lysate) endotoxin testing is applied as a secondary quality checkpoint, and GMP-compliant manufacturing conditions govern the entire production environment.

Usage

  1. Establish your cycle ceiling early.: Begin AnaTrex at the lowest effective dose (20 mg/day) during the first week to benchmark your individual anabolic response before receptor adaptation begins.
  2. Split your daily dose across two or three tablet administrations.: Distributing 10 mg units through the day maintains more consistent receptor occupancy without the prolonged uninterrupted stimulation that accelerates desensitization.
  3. Administer tablets with food.: Taking each dose alongside a meal supports gastric tolerance and consistent tablet disintegration kinetics.
  4. Track anabolic output indicators weekly.: Monitor bodyweight, training performance, and recovery quality as proxy markers; a plateau before week four signals early desensitization onset and warrants cycle-length reconsideration.
  5. Initiate the taper during the final week.: Reducing the daily dose from your peak to 10–20 mg in the last seven days softens the transition into off-phase and supports a smoother receptor recovery trajectory.
  6. Observe a structured off-period equal to or exceeding the cycle length.: Receptor density normalization, as indicated by radioligand binding research in androgen-sensitive tissue, requires a minimum four-to-eight-week drug-free interval before receptor responsiveness is restored for subsequent cycles.

Warnings

Contraindications:

AnaTrex is contraindicated in individuals with existing hepatic impairment, prostate or breast carcinoma, severe cardiovascular disease, or hypersensitivity to 17α-alkylated compounds. Not for use by females of childbearing age or individuals under 18.

Side Effects:

Hepatotoxicity risk increases with duration of use — the 17α-alkylation enabling oral bioavailability also places dose-dependent stress on hepatocyte metabolism. Estrogenic effects (water retention, gynecomastia) arise via aromatase conversion and should be managed with an appropriate aromatase inhibitor. Androgenic effects including acne, sebum overproduction, and accelerated male-pattern hair loss are individually variable. Suppression of endogenous testosterone production begins within the first week of use.

Monitoring:

Liver function panels (AST, ALT, ALP, bilirubin) should be assessed at baseline and at the midpoint of each cycle. Lipid panels — specifically LDL elevation and HDL suppression — require monitoring given Methandienone's documented impact on hepatic lipase activity. Blood pressure should be tracked weekly throughout the cycle.

PCT (Post-Cycle Therapy):

Because endogenous testosterone suppression accompanies receptor desensitization, a structured PCT protocol beginning within 24–72 hours of the final AnaTrex dose is essential. SERMs (e.g., Tamoxifen, Clomiphene) are the standard framework for restoring hypothalamic-pituitary-gonadal axis function during the receptor recovery window.

Frequently asked questions

Does the body develop tolerance to Methandienone, and how does receptor desensitization differ from simple drug tolerance?
Yes — the body develops a specific form of tolerance called androgen receptor desensitization, which is distinct from pharmacokinetic drug tolerance. While pharmacokinetic tolerance involves changes in drug absorption or metabolism, receptor desensitization is a cellular event: prolonged androgen receptor occupancy triggers receptor internalization and reduced re-synthesis, measurably blunting the transcriptional anabolic response even when blood drug levels remain stable.
At what point during a Methandienone cycle does receptor desensitization become clinically significant?
Anabolic response attenuation typically becomes measurable within four to six weeks of continuous use, as documented in sports-pharmacology studies using nitrogen retention as a surrogate endpoint. This is why most evidence-based protocols cap oral Methandienone cycles at six weeks — extending use beyond this window yields diminishing anabolic returns rather than proportional gains, while cumulative hepatic and cardiovascular risks continue to accumulate.
Why are off-cycle breaks necessary after using Methandienone tablets, and how long should they last?
Off-cycle breaks are necessary because androgen receptor density must recover before the next cycle can produce a meaningful anabolic response. Radioligand binding research in androgen-sensitive tissue models indicates receptor population normalization requires approximately four to eight weeks of drug-free time. A break shorter than this window means beginning the next cycle against a partially desensitized receptor pool, which reduces the ceiling of anabolic output from the outset.
How does the 10 mg tablet format of AnaTrex support receptor-tolerance management compared to higher fixed-dose tablets?
The 10 mg unit dose gives users granular control over daily receptor loading, which is practically important for tolerance management. Users can start conservatively at 20 mg/day, assess the anabolic response, and scale to 30–50 mg/day as justified — rather than being locked into a fixed higher dose from the start. This flexibility also supports a structured end-of-cycle taper, which eases the receptor transition into the off-phase recovery period.
Can AnaTrex tablets be split or taken at different times of day to reduce receptor desensitization pressure?
Yes — because each AnaTrex tablet is a discrete 10 mg unit, the daily dose can be distributed across two or three administrations without cutting. Splitting doses spaces receptor stimulation across the day rather than delivering a single large pulse, which some sports-pharmacology practitioners argue moderates the rate of receptor downregulation compared to single-dose bolus protocols. Tablets should be swallowed intact with food to ensure consistent disintegration and gastric tolerance. (2) angle_used

Manufacturer

Concentrex Labs presents AnaTrex in a tablet-based primary packaging format — 100 tablets per container — chosen specifically because discrete unit-dose tablets serve the precise daily titration requirements that receptor-tolerance management demands. Unlike vial-based products in the Concentrex catalogue, where draw volume governs dose accuracy, the tablet format delegates dose control entirely to tablet count: each unit contains exactly 10 mg of Methandienone, confirmed by HPLC potency assay at finished-product stage rather than at raw-material intake alone. The production environment operates under GMP-compliant conditions, and the LAL (Limulus Amebocyte Lysate) endotoxin assay — a regulatory-grade bacterial endotoxin detection method originally adopted for parenteral products — is applied as an additional release checkpoint, with all results documented in the batch record archived against the lot number printed on each container.

Product details

BrandConcentrex Labs
Active ingredientmethandienone
Also known asDianabol, Methandrostenolon, D-Bol, Danabol, AnaTrex, Concentrex Labs Dianabol
Strength10 mg
FormTabletten
Pack size100 pieces
Item numberORA-METH-CON-005

Reviews

4.5/5

2 reviews

  • Rating: 5 out of 5 starsprime36Verified purchase

    best dbol I've used

    kicked in around day 4 at 40mg daily. By week 2 I was up 6kg and moving weights I hadn't touched in months. Used as a 4 week kickstart to a test e cycle. Bloodwork mid-cycle showed test at 1840 ng/dl, hematocrit sat at 47% which was fine. Liver supps a must but compound itself delivered

  • Rating: 4 out of 5 starsdragon_45Verified purchase

    Good product, bit pricey

    does the job no doubt. 30mg ed for 5 weeks gave me good size and strength increase. bit of water retention but that's dbol. only gripe is the price per tab compared to some others I've used. Quality seems legit though, gains felt real and kept a decent amount post cycle with proper pct

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Danabol 10mg/tab 100 Tablets by Balkan PharmaceuticalsLab Tested

Danabol 10mg/tab 100 Tabletten by Balkan Pharmaceuticals

€26.00
Pro-Dynabol 20mg/tab 50 Tablets by Beligas PharmaceuticalsHPLC Verified

Pro-Dynabol 20mg/tab 50 Tabletten by Beligas Pharmaceuticals

€35.00
Danabol 10mg/tab 100 Tablets by Body ResearchPharma Grade

Danabol 10mg/tab 100 Tabletten by Body Research

€85.00
Anabol Tablets 5mg/tab 1000 Tablets by British DispensaryPurity Tested

Anabol Tablets 5mg/tab 1000 Tabletten by British Dispensary

€85.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00